Manufacturer: Novus Biologicals
Pack Size | SKU | Availability | Price |
---|---|---|---|
Each of 1 | NBP275731-Each-of-1 | In Stock | ₹ 55,485.66 |
NBP275731 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 55,485.66
GST (18%): ₹ 9,987.419
Total Price: ₹ 65,473.079
MTAP
Monoclonal
0.2 mg/ml
Western Blot : 0.5-2 ug/ml, ELISA 2 - 4 ug/mL, Immunohistochemistry 1 - 2 ug/mL, Immunohistochemistry-Paraffin : 1-2 ug/ml, Protein Array
5'-methylthioadenosine phosphorylase, c86fus, EC 2.4.2.28, methylthioadenosine phosphorylase, MSAPMeSAdo phosphorylase, MTA phosphorylase, MTAPase, S-methyl-5'-thioadenosine phosphorylase
Mouse
31 kDa
100 μg
4507.0
Human
Purified
Western Blot, ELISA, Immunohistochemistry (Paraffin)
MTAP/1813
Unconjugated
10 mM PBS with No Preservative
MTAP
Recombinant human MTAP protein fragment (aa97-196) (exact sequence is proprietary) (Uniprot: Q13126)
Protein A or G purified
Primary
Recognizes a protein of 31kDa, which is identified as MTAP (5'-deoxy-5'-methylthioadenosine phosphorylase). It catalyzes the reversible phosphorolysis of methylthioadenosine, which is important in polyamine metabolism and for the salvage of adenine and methionine. The gene encoding MTAP is linked to the tumor suppressor gene, p16INK4A. Deficient levels of MTAP can occur in cancers primarily through co-deletion of the MTAP gene and the p16INK4A gene. Cells expressing MTAP and possessing adenine salvage pathway activity may be less susceptible to malignancy due to growth-inhibitory actions of agents (e.g. antifolates), whose mechanism of action, in part, involves this de novo purine pathway.
Store at 4°C.
IgG2b κ